$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000110465913037147 Filed on May 03, 2013

Income Statement

Concept	2013 Q2	2013 Q1	2012 Q1
Revenue	$1.036M	$1.036M	$1.036M
YoY Change	0.0%	0.0%	-0.38%
Cost Of Revenue			$0.00
YoY Change			-100.0%
Gross Profit	$1.036M	$1.036M	$1.036M
YoY Change	0.0%	0.0%	0.19%
Gross Profit Margin	100.0%	100.0%	100.0%
Selling, General & Admin	$6.930M	$4.407M	$2.739M
YoY Change	86.09%	60.9%	11.93%
% of Gross Profit	668.92%	425.39%	264.38%
Research & Development	$6.457M	$7.526M	$8.999M
YoY Change	-47.08%	-16.37%	201.07%
% of Gross Profit	623.26%	726.45%	868.63%
Depreciation & Amortization	$300.0K	$314.0K	$202.0K
YoY Change	50.0%	55.45%	201.49%
% of Gross Profit	28.96%	30.31%	19.5%
Operating Expenses	$13.39M	$11.93M	$11.74M
YoY Change	-15.94%	1.66%	115.93%
Operating Profit	-$12.35M	-$10.90M	-$10.70M
YoY Change	-17.05%	1.82%	143.12%
Interest Expense	$18.00K	$19.00K	$5.000K
YoY Change	260.0%	280.0%	0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$12.30M	-$10.90M	-$10.60M
YoY Change	-16.89%	2.83%	140.91%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$12.30M	-$10.90M	-$10.60M
YoY Change	-16.89%	2.83%	140.91%
Net Earnings / Revenue	-1187.26%	-1052.12%	-1023.17%
Basic Earnings Per Share
Diluted Earnings Per Share	-$190.1K	-$170.8K	-$186.9K
COMMON SHARES
Basic Shares Outstanding	64.10M shares	64.03M shares	57.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q2	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$157.7M	$95.50M	$83.50M
YoY Change	122.43%	14.37%	-6.91%
Cash & Equivalents	$21.52M	$8.053M	$12.29M
Short-Term Investments	$136.2M	$87.40M	$71.20M
Other Short-Term Assets	$1.100M	$1.100M	$1.900M
YoY Change	-52.17%	-42.11%	280.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$158.8M	$96.55M	$85.45M
YoY Change	116.93%	12.98%	-5.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.394M	$3.442M	$2.551M
YoY Change	53.1%	34.93%	155.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.394M	$3.442M	$2.551M
YoY Change	53.1%	34.93%	155.1%
TOTAL ASSETS
Total Short-Term Assets	$158.8M	$96.55M	$85.45M
Total Long-Term Assets	$4.394M	$3.442M	$2.551M
Total Assets	$163.2M	$99.99M	$88.01M
YoY Change	114.52%	13.62%	-3.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.084M	$2.081M	$900.0K
YoY Change	35.5%	131.22%	12.5%
Accrued Expenses	$4.227M	$3.345M	$2.600M
YoY Change	14.24%	28.65%	85.71%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$300.0K
YoY Change
Total Short-Term Liabilities	$8.019M	$9.165M	$7.692M
YoY Change	-7.18%	19.15%	20.19%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities	$100.0K	$100.0K	$3.500M
YoY Change	-95.83%	-97.14%	-53.95%
Total Long-Term Liabilities	$1.000M	$1.000M	$4.500M
YoY Change	-70.59%	-77.78%	-47.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.019M	$9.165M	$7.692M
Total Long-Term Liabilities	$1.000M	$1.000M	$4.500M
Total Liabilities	$9.019M	$10.17M	$12.10M
YoY Change	-25.46%	-15.99%	-19.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$297.4M	-$285.1M
YoY Change
Common Stock	$451.0M	$374.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$153.6M	$89.13M	$75.86M
YoY Change
Total Liabilities & Shareholders Equity	$163.2M	$99.99M	$88.01M
YoY Change	114.52%	13.62%	-3.5%

Cashflow Statement

Concept	2013 Q2	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$12.30M	-$10.90M	-$10.60M
YoY Change	-16.89%	2.83%	140.91%
Depreciation, Depletion And Amortization	$300.0K	$314.0K	$202.0K
YoY Change	50.0%	55.45%	201.49%
Cash From Operating Activities	-$9.900M	-$12.10M	-$11.20M
YoY Change	-19.51%	8.04%	103.64%
INVESTING ACTIVITIES
Capital Expenditures	-$1.300M	$376.0K	$195.0K
YoY Change	160.0%	92.82%	-20.41%
Acquisitions
YoY Change
Other Investing Activities	-$49.00M	$7.200M	-$13.70M
YoY Change	-877.78%	-152.55%	1270.0%
Cash From Investing Activities	-$50.30M	$6.800M	-$13.90M
YoY Change	-967.24%	-148.92%	1058.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$73.30M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	73.60M	0.000	1.600M
YoY Change	24433.33%	-100.0%
NET CHANGE
Cash From Operating Activities	-9.900M	-12.10M	-11.20M
Cash From Investing Activities	-50.30M	6.800M	-13.90M
Cash From Financing Activities	73.60M	0.000	1.600M
Net Change In Cash	13.40M	-5.300M	-23.50M
YoY Change	-316.13%	-77.45%	250.75%
FREE CASH FLOW
Cash From Operating Activities	-$9.900M	-$12.10M	-$11.20M
Capital Expenditures	-$1.300M	$376.0K	$195.0K
Free Cash Flow	-$8.600M	-$12.48M	-$11.40M
YoY Change	-27.12%	9.49%	98.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	955000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	57170000	USD
CY2013Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	13600000	USD
CY2013Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y4D
CY2013Q1	us-gaap	Assets Current AssetsCurrent	96549000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13345000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	78000	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	94776000	USD
CY2013Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	87429000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	94776000	USD
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7695000	shares
CY2013Q1	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	165000	shares
CY2013Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 20pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</font></p></div>
CY2012Q1	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	250000	shares
CY2013Q1	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
CY2013Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	283000	USD
CY2013Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	28000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5490000	USD
CY2012Q1	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1035000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2169000	USD
CY2012Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2528000	USD
CY2013Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	87358000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	94698000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	71000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8053000	USD
CY2013Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	87429000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1067000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	593000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	108714000	USD
CY2013Q1	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	4324000	USD
CY2013Q1	exas	Office And Computer Equipment Gross OfficeAndComputerEquipmentGross	855000	USD
CY2013Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2048000	USD
CY2013Q1	us-gaap	Assets Assets	99991000	USD
CY2012Q4	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	4051000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3442000	USD
CY2012Q4	exas	Office And Computer Equipment Gross OfficeAndComputerEquipmentGross	824000	USD
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	283000	USD
CY2012Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	28000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112119000	USD
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64093730	shares
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5186000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1781000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3405000	USD
CY2012Q4	us-gaap	Assets Assets	112119000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2081000	USD
CY2013Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3345000	USD
CY2013Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	337000	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3402000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9165000	USD
CY2013Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2013Q1	exas	Interest Payable Noncurrent InterestPayableNoncurrent	68000	USD
CY2013Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	625000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3652000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3327000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	333000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4143000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11455000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2012Q4	exas	Interest Payable Noncurrent InterestPayableNoncurrent	63000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	711000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	295000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	641000	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	373520000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	71000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-285099000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	89133000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	99991000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	639000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	372123000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	78000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274245000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	98595000	USD
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63909800	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64093730	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63909800	shares
CY2013Q1	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
CY2012Q1	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1759000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1571000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7526000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2648000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	184000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-195000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	372000	USD
CY2013Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5000	USD
CY2012Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5000	USD
CY2012Q1	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-1036000	USD
CY2012Q1	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	27000	USD
CY2013Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	140000	USD
CY2012Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	104000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	474000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	884000	USD
CY2013Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	9231000	USD
CY2012Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	29963000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	16431000	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	16230000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	376000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	195000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	11933000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8999000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2145000	USD
CY2012Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	594000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	11738000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10897000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10702000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	62000	USD
CY2012Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	62000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	19000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	5000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10854000	USD
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10645000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63836000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56718000	shares
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10861000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10610000	USD
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	EXACT SCIENCES CORP
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001124140
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	64095153	shares
CY2013Q1	us-gaap	Depreciation Depreciation	314000	USD
CY2012Q1	us-gaap	Depreciation Depreciation	202000	USD
CY2013Q1	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-1036000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	6824000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13928000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	90000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1642000	USD
CY2013Q1	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-7000	USD
CY2013Q2	exas	Vesting Rights Percentage VestingRightsPercentage	0.25	pure
CY2013Q2	exas	Vesting Rights Number Of Annual Installments VestingRightsNumberOfAnnualInstallments	3	item
CY2013Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2012Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2013Q1	exas	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	30259000	USD
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7654000	shares
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	58362000	USD
CY2013Q1	exas	Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost	28997000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	87359000	USD
CY2013Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	5685	USD
CY2012Q1	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	35000	USD
CY2013Q1	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	354000	USD
CY2012Q1	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	274000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12124000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-11203000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	8000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1642000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-5292000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-23489000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12292000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35781000	USD
CY2013Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	30534	shares
CY2012Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	32872	shares
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-7000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	35000	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2013Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	4800	USD

Files In Submission

Name	View Source	Status
0001104659-13-037147-index-headers.html	Edgar Link	pending
0001104659-13-037147-index.html	Edgar Link	pending
0001104659-13-037147.txt	Edgar Link	pending
0001104659-13-037147-xbrl.zip	Edgar Link	pending
a13-7474_110q.htm	Edgar Link	pending
a13-7474_1ex31d1.htm	Edgar Link	pending
a13-7474_1ex31d2.htm	Edgar Link	pending
a13-7474_1ex32d1.htm	Edgar Link	pending
exas-20130331.xml	Edgar Link	completed
exas-20130331.xsd	Edgar Link	pending
exas-20130331_cal.xml	Edgar Link	unprocessable
exas-20130331_def.xml	Edgar Link	unprocessable
exas-20130331_lab.xml	Edgar Link	unprocessable
exas-20130331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2013 Q2 Form 10-Q Financial Statement

#000110465913037147 Filed on May 03, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2013 Q2 Form 10-Q Financial Statement

#000110465913037147 Filed on May 03, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas